François-Maurice Garnier
Directeur/Bestuurslid bij ALBIREO PHARMA, INC.
Actieve functies van François-Maurice Garnier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IPSEN | Algemeen Adviseur | 05-01-2015 | - |
| EPIZYME, INC. | Directeur/Bestuurslid | 12-08-2022 | - |
| ALBIREO PHARMA, INC. | Directeur/Bestuurslid | 02-03-2023 | - |
| Union des Fabricants | Directeur/Bestuurslid | - | - |
Ipsen Consumer Healthcare SAS
 Ipsen Consumer Healthcare SAS Pharmaceuticals: MajorHealth Technology Part of Scorpius SAS, Ipsen Consumer Healthcare SAS operates as a French biopharmaceutical company. The company is based in Boulogne-Billancourt, France. The company was founded in 2004. Axelle Arnault de la Ménardière has been the CEO of the company since 2020. Ipsen Consumer Healthcare was acquired by Laboratoires Mayoly Spindler SAS from Ipsen SA on July 28, 2022 for $401.36 million. | Voorzitter | 21-05-2019 | - |
Loopbaan van François-Maurice Garnier
Eerdere bekende functies van François-Maurice Garnier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Pfizer Holding France SCA
 Pfizer Holding France SCA Pharmaceuticals: MajorHealth Technology Pfizer Holding France SCA manufactures and supplies pharmaceutical products. The company was founded in 1961 and is headquartered in Paris, France. | Algemeen Adviseur | 01-01-2009 | 01-01-2014 |
Aventis Animal Nutrition SA
 Aventis Animal Nutrition SA Agricultural Commodities/MillingProcess Industries Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France. | Algemeen Adviseur | - | 01-01-2001 |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Corporate Officer/Principal | 01-01-1989 | 01-09-1995 |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Algemeen Adviseur | 01-01-1995 | - |
| ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van François-Maurice Garnier
| Université Paris II Panthéon Assas | Undergraduate Degree |
Statistieken
Internationaal
| Frankrijk | 10 |
| Verenigde Staten | 4 |
Operationeel
| General Counsel | 5 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 9 |
| Process Industries | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IPSEN | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Aventis Animal Nutrition SA
Aventis Animal Nutrition SA Agricultural Commodities/MillingProcess Industries Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France. | Process Industries |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| Union des Fabricants | |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Health Technology |
Pfizer Holding France SCA
Pfizer Holding France SCA Pharmaceuticals: MajorHealth Technology Pfizer Holding France SCA manufactures and supplies pharmaceutical products. The company was founded in 1961 and is headquartered in Paris, France. | Health Technology |
Ipsen Consumer Healthcare SAS
Ipsen Consumer Healthcare SAS Pharmaceuticals: MajorHealth Technology Part of Scorpius SAS, Ipsen Consumer Healthcare SAS operates as a French biopharmaceutical company. The company is based in Boulogne-Billancourt, France. The company was founded in 2004. Axelle Arnault de la Ménardière has been the CEO of the company since 2020. Ipsen Consumer Healthcare was acquired by Laboratoires Mayoly Spindler SAS from Ipsen SA on July 28, 2022 for $401.36 million. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
